Tilray Inc (TLRY) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported TLRY revenue for 2026-05-31 was $915.5M. Net income was -$121.4M. Revenue was up 11.5% from 2025-05-31 to 2026-05-31. TLRY currently screens at market cap $573.9M.
Use this TLRY page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the TLRY quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the TLRY SEC filings page. Lician reads the product cache first so this HTML stays unique to Tilray Inc even when a live quote feed is slow.
Latest cached year on this hub. Full TLRY income, balance, and cash tables.